Sanofi buys US biopharma group Blueprint in $9.1 billion deal

Technology & Startups

Sanofi buys US biopharma group Blueprint in $9.1 billion deal

June 2, 2025

PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical company specializing in systemic ...

Tag: systemic mastocytosis

Sanofi buys US biopharma group Blueprint in $9.1 billion deal

Family calls for change after B.C. nurse dies by suicide after attacks on the job

Product reduces TPH levels to non-hazardous status

Hospital Mergers Fail to Deliver Better Care or Lower Costs, Study Finds todayheadline

Police ID man who died after Corso Italia fight

Harris tells supporters ‘never give up’ and urges peaceful transfer of power

Des Moines Man Accused Of Shooting Ex-Girlfriend’s Mother

Trump ‘looks forward’ to White House meeting with Biden

Catholic voters were critical to Donald Trump’s blowout victory: ‘Harris snubbed us’

Slain Minnesota House Speaker Melissa Hortman laid to rest

Live updates: Senate GOP works to finesse ‘big, beautiful bill’ language as critical vote looms

Chinese aircraft carrier-led fleet to visit Hong Kong for 5 days

Death toll rises after Pakistan hit by flash floods and heavy rains

Recent News

Slain Minnesota House Speaker Melissa Hortman laid to rest

Live updates: Senate GOP works to finesse ‘big, beautiful bill’ language as critical vote looms

Chinese aircraft carrier-led fleet to visit Hong Kong for 5 days

Death toll rises after Pakistan hit by flash floods and heavy rains

Browse by Category

Recent News

Slain Minnesota House Speaker Melissa Hortman laid to rest

Live updates: Senate GOP works to finesse ‘big, beautiful bill’ language as critical vote looms